Vicks Nyquil Severe
Pricing Report NDC 37000-813-24

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Vicks Nyquil Severe Cold And Flu (NDC 37000-813-24) is $0.44718 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 23, 2015.

As a provided by The Procter & Gamble Manufacturing Company, this medication is distributed in a 12 BLISTER PACK in 1 CARTON / 2 TABLET, COATED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.44718
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Dec 23, 2015
Data Status
As of Mar 30, 2016
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
37000-813-24
Description
12 BLISTER PACK in 1 CARTON / 2 TABLET, COATED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.37255 to $0.44718 per EA. Over this 1 year and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.3726 - $0.4472
Market Volatility
20.03% Variance
Latest Trend
20.03%
Date Unit Price Unit Source Method Rate
Dec 23, 2015 $0.44718 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Dec 23, 2015 $0.44718 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 23, 2015 $0.44718 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Dec 23, 2015 $0.44718 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Nov 02, 2015 $0.37255 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Nov 02, 2015 $0.37255 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Nov 02, 2015 $0.37255 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Nov 02, 2015 $0.37255 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Nov 19, 2014 $0.37317 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 19, 2014 $0.37317 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Nov 19, 2014 $0.37317 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 19, 2014 $0.37317 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026